Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY)   2016 , Volume 4 , Number 2 ; Page(s) 92 To 96.
 
Paper: 

REMIFENTANIL VERSUS FENTANYL/MIDAZOLAM IN PAINLESS REDUCTION OF ANTERIOR SHOULDER DISLOCATION, A RANDOMIZED CLINICAL TRIAL

 
 
Author(s):  GHARAVIFARD MOHAMMAD, TAFAKORI AZADEH*, ZAMANIMOGHADAM HAMID
 
* EMERGENCY DEPARTMENT, EMAM REZA HOSPITAL, MASHHAD, IRAN
 
Abstract: 

Introduction: Performance of painful diagnostic and therapeutic procedures is common in emergency department (ED), and procedural sedation and analgesia (PSA) is a fundamental skill for every emergency physician.
This studywas aim to compare the efficacy of remifentanil with fentanyl/midazolam in painless reduction of anterior shoulder dislocation.
Methods: In this randomized, double blind, clinical trial the procedural characteristics, patients satisfaction as well as adverse events were compared between fentanyl/midazolamand remifentanil for PSA of 18-64 years old patients, which were presented to ED following anterior shoulder dislocation.
Results: 96 cases were randomly allocated to two groups (86.5% male). There were no significant difference between groups regarding baseline characteristics. Remifentanil group had lower duration of procedure (2.5
±1.6 versus 4.6±1.8 minutes, p<0.001), higher pain reduction (53.7±13.3 versus 33.5±19.6, p<0.001), lower failure rate (1 (2.1%) versus 15 (31.3%), p<0.001), higher satisfaction (p=0.005). Adverse events were seen in 12 (25%) patients in midazolam/fentanyl and 8 (16.7%) cases in remifentanil group (p=0.122).
Conclusion: It seems that use of remifentanil resulted in lower procedural time, lower failure rate, and lower pain during procedure as well as higher patient satisfaction in comparison with midazolam/fentanyl combination in anterior shoulder dislocation.

 
Keyword(s): CONSCIOUS SEDATION, MIDAZOLAM, FENTANYL, REMIFENTANIL [SUPPLEMENTARY CONCEPT], SHOULDER DISLOCATION
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

GHARAVIFARD, M., & TAFAKORI, A., & ZAMANIMOGHADAM, H. (2016). REMIFENTANIL VERSUS FENTANYL/MIDAZOLAM IN PAINLESS REDUCTION OF ANTERIOR SHOULDER DISLOCATION, A RANDOMIZED CLINICAL TRIAL. ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY), 4(2), 92-96. https://www.sid.ir/en/journal/ViewPaper.aspx?id=510047



Vancouver: Copy

GHARAVIFARD MOHAMMAD, TAFAKORI AZADEH, ZAMANIMOGHADAM HAMID. REMIFENTANIL VERSUS FENTANYL/MIDAZOLAM IN PAINLESS REDUCTION OF ANTERIOR SHOULDER DISLOCATION, A RANDOMIZED CLINICAL TRIAL. ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY). 2016 [cited 2021July24];4(2):92-96. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=510047



IEEE: Copy

GHARAVIFARD, M., TAFAKORI, A., ZAMANIMOGHADAM, H., 2016. REMIFENTANIL VERSUS FENTANYL/MIDAZOLAM IN PAINLESS REDUCTION OF ANTERIOR SHOULDER DISLOCATION, A RANDOMIZED CLINICAL TRIAL. ARCHIVES OF ACADEMIC EMERGENCY MEDICINE (EMERGENCY), [online] 4(2), pp.92-96. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=510047.



 
  pdf-File
Yearly Visit 51
 
 
Latest on Blog
Enter SID Blog